Antony C. Mattessich is the President and CEO of Ocular Therapeutix, a company focused on developing innovative ocular therapies. He joined the company in July 2017 and has a history of strong performance. In 2023, he received total compensation of...
Antony C. Mattessich is the President and CEO of Ocular Therapeutix, a company focused on developing innovative ocular therapies. He joined the company in July 2017 and has a history of strong performance. In 2023, he received total compensation of approximately $3.28 million, which included a salary of $686,400 and a bonus tied directly to the company's performance. This marks a significant growth in his compensation and reflects the company's success during his tenure. His leadership is evident in the strategic decision-making that has led to Ocular Therapeutix's growth and innovation in the pharmaceutical sector. Mattessich has been actively trading company stocks, showing confidence in Ocular’s future, with notable trades peaking at over $9 million in a single month. His decisions have raised the stakes for Ocular Therapeutix as they navigate the development of new treatments. Before joining Ocular, he had significant experience at various companies, thereby bringing valuable insights to the team. His trajectory and decisions are watched closely by investors and analysts alike, as he continues to steer Ocular Therapeutix towards greater achievements.